Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
53,000
Employees53,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
53,000
Employees53,000

BSX Key Statistics

Market cap
110.81B
Market cap110.81B
Price-Earnings ratio
38.52
Price-Earnings ratio38.52
Dividend yield
Dividend yield
Average volume
27.99M
Average volume27.99M
High today
$76.37
High today$76.37
Low today
$74.20
Low today$74.20
Open price
$74.54
Open price$74.54
Volume
13.45M
Volume13.45M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$72.69
52 Week low$72.69

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $74.72. The company's market cap stands at 110.81B, with a P/E ratio of 38.52.

On 2026-02-16, Boston Scientific(BSX) stock moved within a range of $74.20 to $76.37. With shares now at $74.72, the stock is trading +0.7% above its intraday low and -2.2% below the session's peak.

Trading activity shows a volume of 13.45M, compared to an average daily volume of 27.99M.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $72.69.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $72.69.

BSX News

Simply Wall St 7h
A Look At Boston Scientific Valuation As Electrophysiology Concerns Follow Strong Q4 Earnings

Boston Scientific (BSX) is back in focus after Q4 2025 adjusted earnings came in above consensus. However, investor attention has shifted to signs of stagnation...

A Look At Boston Scientific Valuation As Electrophysiology Concerns Follow Strong Q4 Earnings
Simply Wall St 2d
Is It Time To Reassess Boston Scientific After Its Recent Share Price Slide

If you are wondering whether Boston Scientific's current share price still reflects its long term potential, looking closely at what you are getting for the pri...

Is It Time To Reassess Boston Scientific After Its Recent Share Price Slide
Simply Wall St 3d
Does Boston Scientific’s 2026 Double-Digit Sales Outlook and Leadership Shift Change The Bull Case For BSX?

Boston Scientific’s fourth-quarter 2025 results, reported on February 4, 2026, showed sales rising to US$5,286 million and net income to US$672 million, alongsi...

Does Boston Scientific’s 2026 Double-Digit Sales Outlook and Leadership Shift Change The Bull Case For BSX?

Analyst ratings

97%

of 35 ratings
Buy
97.1%
Hold
2.9%
Sell
0%

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.